11 Results for "

disease-modifying

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "disease-modifying" in MCE Product Catalog:

17
17 Cited Publications
Cat. No.: HY-B0083
CAS No.: 75706-12-6
Synonyms: HWA486; RS-34821; SU101
Leflunomide is a pyrimidine synthesis inhibitor, inhibiting dihydroorotate dehydrogenase (DHODH), and acts as a disease-modifying antirheumatic agent.
loading...
    loading...
Cat. No.: HY-11044
CAS No.: 1039399-17-1
Purity:  99.1%
PF-03654746 Tosylate is a potent, selective and brain-penetrant histamine H3 receptor antagonist. PF-03654746 Tosylate reduces allergen-induced nasal symptoms . PF-03654746 Tosylate has potential for treatment of human cognitive disorders, improves cognitive efficacy and disease-modifying effects in Alzheimer's disease (AD) .
loading...
    loading...
Cat. No.: HY-W010744
CAS No.: 93778-57-5
Synonyms: 5'-O-DMT-dI; 2'-Deoxy-5'-O-DMT-inosine
Research Areas:  

Cancer

DMT-dI (5'-O-DMT-dI) is a deoxyribonucleoside containing a hypoxanthine base. DMT-dI can be used to prepare convertible nucleoside derivatives to prepare modified oligonucleotides complementary to target genes for gene editing. DMT-dI can be used to study various conditions, disorders or diseases modified by adenosine .
loading...
    loading...
Cat. No.: HY-150307
CAS No.: 2082765-42-0
Purity:  99.78%
Research Areas:  

Inflammation/Immunology

KP-302 (Compound 23) is a selective inhibitor of protein arginine deaminase PAD2 with a Ki of 60 μM. KP-302 also reverses physical disability in the EAE mouse model of multiple sclerosis (MS) and eliminates T cell infiltration in the brain. KP-302 can be studied in research as a disease-modifying agent for MS .
loading...
    loading...
Cat. No.: HY-B0083S
CAS No.: 1189987-23-2
Leflunomide-d4 (HWA486-d4) is the deuterium labeled Leflunomide. Leflunomide is a pyrimidine synthesis inhibitor, inhibiting dihydroorotate dehydrogenase (DHODH), and acts as a disease-modifying antirheumatic agent .
loading...
    loading...
Cat. No.: HY-11045
CAS No.: 935840-31-6
PF-03654746 is a potent and selective histamine H3 receptor antagonist with high brain penetration. PF-03654746 reduces allergen-induced nasal symptoms, might be a novel therapeutic strategy to further explore allergic rhinitis . PF-03654746 improves cognitive efficacy and disease-modifying effects in Alzheimer's disease (AD) .
loading...
    loading...
Cat. No.: HY-B0083R
CAS No.: 75706-12-6
Synonyms: HWA486 (Standard); RS-34821 (Standard); SU101 (Standard)
Leflunomide (Standard) is the analytical standard of Leflunomide. This product is intended for research and analytical applications. Leflunomide is a pyrimidine synthesis inhibitor, inhibiting dihydroorotate dehydrogenase (DHODH), and acts as a disease-modifying antirheumatic agent.
loading...
    loading...
Cat. No.: HY-B0083S1
Synonyms: HWA486-13C6; RS-34821-13C6; SU101-13C6
Leflunomide- 13C6 (HWA486- 13C6) is 13C labeled Leflunomide. Leflunomide is a pyrimidine synthesis inhibitor, inhibiting dihydroorotate dehydrogenase (DHODH), and acts as a disease-modifying antirheumatic agent.
loading...
    loading...
Cat. No.: HY-156102
CAS No.: 3056613-20-5
Target:  

Bcr-Abl

Research Areas:  

Neurological Disease

c-ABL-IN-5 is a selective c-Abl inhibitor with neuroprotective effects. c-ABL-IN-5 has blood-brain barrier penetrability, metabolic stability and good pharmacokinetic properties. When c-ABL-IN-5 is labeled with [18F] (compound [18F]3), it can be used as a tracer to evaluate disease-modifying efficacy by complementary positron emission tomography (PET). c-ABL-IN-5 can be used in the study of neurodegenerative diseases such as Parkinson's disease (PD) .
loading...
    loading...
Cat. No.: HY-136813
CAS No.: 2205015-77-4
Multitarget AD inhibitor-1 is a selective and reversible butyrylcholinesterase (BuChE) inhibitor with IC50s of 7.22 μM and 1.55 μM for hBuChE and eqBuChE (BuChE from equine serum), respectively. Multitarget AD inhibitor-1 inhibits β-secretase (IC50hBACE-1=41.60 μM), amyloid β aggregation (IC50Aβ=3.09 μM), tau aggregation. Multitarget AD inhibitor-1, a diphenylpropylamine derivative, has the potential for multifunctional disease-modifying anti-Alzheimer’s research .
loading...
    loading...
Cat. No.: HY-170887
CAS No.: 3094045-97-0
Research Areas:  

Inflammation/Immunology

MAO-B-IN-39 (compound11) is a selective monoamine oxidase B (MAO-B) inhibitor. MAO-B-IN-39 inhibits MAO-Bwith an IC50 of 3.61 μM. MAO-B-IN-39 demonstrates a potent NRF2 induction capacity. MAO-B-IN-39 exhibits potent anti-inflammatory and neuroprotective activity in OS (oxidative stress)-related in vitro models. MAO-B-IN-39 demonstrates high liver microsomal stability and favorable pharmacokinetics in mice. MAO-B-IN-39 is potential for Parkinson’s disease (PD) research .
loading...
    loading...
  • 1